ArcticZymes Technologies Management
Management criteria checks 3/4
ArcticZymes Technologies' CEO is Jethro Holter, appointed in Oct 2019, has a tenure of 3.33 years. total yearly compensation is NOK2.74M, comprised of 69.1% salary and 30.9% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth NOK3.32M. The average tenure of the management team and the board of directors is 3.1 years and 1.6 years respectively.
Key information
Jethro Holter
Chief executive officer
NOK 2.7m
Total compensation
CEO salary percentage | 69.1% |
CEO tenure | 3.3yrs |
CEO ownership | 0.2% |
Management average tenure | 3.1yrs |
Board average tenure | 1.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2022 | n/a | n/a | NOK 33m |
Sep 30 2022 | n/a | n/a | NOK 47m |
Jun 30 2022 | n/a | n/a | NOK 52m |
Mar 31 2022 | n/a | n/a | NOK 48m |
Dec 31 2021 | NOK 3m | NOK 2m | NOK 46m |
Sep 30 2021 | n/a | n/a | NOK 68m |
Jun 30 2021 | n/a | n/a | NOK 67m |
Mar 31 2021 | n/a | n/a | NOK 84m |
Dec 31 2020 | NOK 2m | NOK 2m | NOK 74m |
Sep 30 2020 | n/a | n/a | NOK 43m |
Jun 30 2020 | n/a | n/a | NOK 37m |
Mar 31 2020 | n/a | n/a | NOK 8m |
Dec 31 2019 | NOK 1m | NOK 1m | -NOK 1m |
Sep 30 2019 | n/a | n/a | -NOK 9m |
Jun 30 2019 | n/a | n/a | -NOK 10m |
Mar 31 2019 | n/a | n/a | -NOK 13m |
Dec 31 2018 | NOK 2m | NOK 1m | -NOK 14m |
Sep 30 2018 | n/a | n/a | -NOK 20m |
Jun 30 2018 | n/a | n/a | -NOK 27m |
Mar 31 2018 | n/a | n/a | -NOK 27m |
Dec 31 2017 | NOK 2m | NOK 1m | -NOK 25m |
Sep 30 2017 | n/a | n/a | -NOK 26m |
Jun 30 2017 | n/a | n/a | -NOK 24m |
Mar 31 2017 | n/a | n/a | -NOK 21m |
Dec 31 2016 | NOK 2m | NOK 1m | -NOK 20m |
Compensation vs Market: Jethro's total compensation ($USD267.08K) is below average for companies of similar size in the UK market ($USD745.84K).
Compensation vs Earnings: Jethro's compensation has been consistent with company performance over the past year.
CEO
Jethro Holter (50 yo)
3.3yrs
Tenure
NOK 2,739,000
Compensation
Dr. Jethro Holter has been Chief Executive Officer of ArcticZymes Technologies ASA (formerly known as Biotec Pharmacon ASA) since April 22, 2020. He was an Interim CEO at Biotec Pharmacon ASA since October...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 3.3yrs | NOK 2.74m | 0.16% NOK 3.3m | |
Chief Financial Officer | 8.3yrs | NOK 1.92m | 0.050% NOK 1.0m | |
Vice President of Operations | 3.1yrs | NOK 1.34m | 0.040% NOK 837.2k | |
Chief Scientific Officer | less than a year | no data | no data | |
Vice President of Business Development & Marketing | 1.1yrs | no data | no data |
3.1yrs
Average Tenure
52yo
Average Age
Experienced Management: AZTO's management team is considered experienced (3.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairperson | 4.8yrs | NOK 470.00k | no data | |
Director | 2.1yrs | NOK 165.00k | 0.020% NOK 413.6k | |
Employee Elected Director | 1.1yrs | no data | 0.00040% NOK 8.3k | |
Employee Elected Observer | 1.1yrs | no data | 0.0061% NOK 127.2k |
1.6yrs
Average Tenure
Experienced Board: AZTO's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.